Skip to main content
. 2016 May 4;7(23):34752–34758. doi: 10.18632/oncotarget.9158

Table 1. The characteristics of patients with TP53 alteration (+: altered; −: unaltered).

YWHAZ (−) TP53 (+) YWHAZ (+) TP53 (+) P Value
Age (Mean ± SD) 67.69 ± 9.12 66.33 ± 11.11 0.823
Gender (n%) Male 37 (56.1) 13 (19.7) 0.556
Female 13 (19.7) 3 (4.5)
T (n%) 2 14 (21.2) 4 (6.1) 0.925
3 22 (33.3) 8 (12.1)
4 7 (10.6) 2 (3.0)
Tx 7 (10.6) 2 (3.0)
N (n%) 0 28 (42.4) 6 (9.1) 0.215
1 4 (6.1) 3 (4.5)
2 9 (13.6) 5 (7.6)
3 4 (6.1) 0 (0)
Nx 5 (7.6) 2 (3.0)
M (n%) 0 26 (39.3) 10 (15.1) 0.385
1 2 (3.0) 0 (0)
Mx 22 (33.3) 6 (9.1)
Living Status (n%) Living 21 (31.8) 10 (15.1) 0.153
Decreased 29 (43.9) 6 (9.1)